Then theres tirzepatide (Mounjaro, Zepbound), a newer medication that not only targets GLP-1 but also GIP receptors, and studies show it may deliver even greater weight loss results and metabolic benefits
These effects are mediated through GLP-1 receptors (GLP-1R), which are widely distributed throughout the body, including the pancreas, liver, skeletal muscle, gastrointestinal tract, cardiovascular system, and central nervous system
So here is the comparison that drives every purchasing decision in this space
This model prioritizes provider relationship, medication transparency, and personalization tools over transactional convenience alone
After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April